CTL banner 2015

VMG Banner 

As the trend toward outsourcing clinical research continues to grow, those charged with vendor qualification, selection, contracting, and ongoing oversight must be ready to meet these expectations. Most importantly, they must consider quality systems-based approaches, risk mitigation and management, and effective tools and techniques for ensuring successful third party vendor partnerships. At CHI’s fourth annual Vendor Management in Clinical Trials conference, thought-leaders will address important themes, including quality systems-based vendor management throughout the lifecycle, risk-based auditing of third party vendors, and addressing quality issues to ensure compliance. We are seeking submissions for presentations and hands-on activities that address these crucial issues and more.

We invite presentations on topics such as: 

  • Implementing a Quality Management Approach to Clinical Vendor Oversight
  • Risk-Based Approaches and Tools for Vendor Qualification and Selection
  • Contracting Quality: Defining the Scope of Work, Budgeting, Quality, and Accountability into the Contract
  • Targeted Risk-Based Auditing of Third Party Vendors: Ensuring Compliance and Identifying and Mitigating Risk
  • Sponsor/CRO Partnership Models for Risk-Based Monitoring: Mitigating Risk, Delivering High Quality Data, and Improving Efficiency
  • Navigating Bumps in the Road with Your Third Party Vendor: Getting Back on Track
  • Root Cause Analysis and Corrective and Preventative Action Plans to Ensure Timeliness
  • Strategies for Managing the Partnership: Project Management and Communications Strategies
  • Effective Ongoing Vendor Oversight: Optimizing Compliance, Proactively Identifying Risk, and Communicating Effectively
  • Risk-Based Approaches to Protocol Development to Ensure Successful Deployment with Your Clinical Research Organization
  • Ensuring that Your Third Party Vendors are Inspection Ready
  • Global Vendor Management: Special Considerations when Contracting Internationally, including in Emerging Regions
  • Addressing Quality Issues: Corrective and Preventive Actions (CAPA), Follow-Up, and Escalation Plans and Procedures

Industry professionals with best practice case studies and other thought leaders are encouraged to submit a session title, summary of a proposed presentation, and brief biography for consideration. To submit a proposal for consideration, please click here 

The deadline for priority consideration is November 26, 2014. 

All proposals are subject to review by the program Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biotech companies, regulators, and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more information, please contact:
Rachel Meyers
Director
Barnett International
a division of Cambridge Healthtech Institute
Email: rmeyers@barnettinternational.com
Phone: 781-247-6269

For exhibit & sponsorship information, please contact:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute
Email: iquigley@healthtech.com
Phone: 781-972-5457

For media & association partnerships, please contact:
James Prudhomme
Senior Marketing Manager
Cambridge Healthtech Institute
Email: jprudhomme@healthtech.com
Phone: 781-972-5486